If you have been going over the detail of the transaction, you will note ' 2.5 million provides shareholders the opportunity to participate in the future of the company on the same basis as the Cho Group'
All those countries you listed with lax regulations treating all sorts of cancers... how does that help Invion?
Our licence will be for Australia and N.Z.... individual trials could take 20 years plus. By the way in 2011 the Malaysian Ministry of Health found ' no retrievable scientific evidence of the effectiveness, safety and cost effectiveness of NGPDT'.
IVX Price at posting:
0.4¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)